Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Aaron Runkle

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Cancer Letters|June 8, 2013
Tight junction proteins: from barrier to tumorigenesisE Aaron Runkle, David Mu
Methods in Molecular Biology (Clifton, N.J.)|November 18, 2010
The blood-retinal barrier: structure and functional significanceE Aaron Runkle, David A Antonetti
Pharmacogenetics and Genomics|October 13, 2005
Genotype-phenotype correlation between the polymorphic UGT2B17 gene deletion and NNAL glucuronidation activities in human liver microsomesPhilip Lazarus, Yan Zheng, E Aaron Runkle, et al.
The Journal of Biological Chemistry|July 16, 2011
Occludin localizes to centrosomes and modifies mitotic entryE Aaron Runkle, Jeffrey M Sundstrom, Kristin B Runkle, et al.
Cell Cycle (Georgetown, Tex.)|December 22, 2011
MiR-365 regulates lung cancer and developmental gene thyroid transcription factor 1Ji Qi, Shawn J Rice, Anna C Salzberg, et al.
The Journal of Biological Chemistry|July 5, 2012
Occludin is a direct target of thyroid transcription factor-1 (TTF-1/NKX2-1)E Aaron Runkle, Shawn J Rice, Ji Qi, et al.
The Journal of Biological Chemistry|April 30, 2013
MicroRNA-33a mediates the regulation of high mobility group AT-hook 2 gene (HMGA2) by thyroid transcription factor 1 (TTF-1/NKX2-1)Shawn J Rice, Shao-Chiang Lai, Lauren W Wood, et al.
The American Journal of Pathology|July 18, 2016
Occludin S490 Phosphorylation Regulates Vascular Endothelial Growth Factor-Induced Retinal NeovascularizationXuwen Liu, Alyssa Dreffs, Monica Díaz-Coránguez, et al.
Cell Reports|September 15, 2015
Disabling of the erbB Pathway Followed by IFN-γ Modifies Phenotype and Enhances Genotoxic Eradication of Breast TumorsYasuhiro Nagai, Hiromichi Tsuchiya, E Aaron Runkle, et al.
Experimental and Molecular Pathology|October 2, 2012
Reversion of the ErbB malignant phenotype and the DNA damage responseE Aaron Runkle, Hongtao Zhang, Zheng Cai, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Cancer Letters|June 8, 2013
Tight junction proteins: from barrier to tumorigenesisE Aaron Runkle, David Mu
Methods in Molecular Biology (Clifton, N.J.)|November 18, 2010
The blood-retinal barrier: structure and functional significanceE Aaron Runkle, David A Antonetti
Pharmacogenetics and Genomics|October 13, 2005
Genotype-phenotype correlation between the polymorphic UGT2B17 gene deletion and NNAL glucuronidation activities in human liver microsomesPhilip Lazarus, Yan Zheng, E Aaron Runkle, et al.
The Journal of Biological Chemistry|July 16, 2011
Occludin localizes to centrosomes and modifies mitotic entryE Aaron Runkle, Jeffrey M Sundstrom, Kristin B Runkle, et al.
Cell Cycle (Georgetown, Tex.)|December 22, 2011
MiR-365 regulates lung cancer and developmental gene thyroid transcription factor 1Ji Qi, Shawn J Rice, Anna C Salzberg, et al.
The Journal of Biological Chemistry|July 5, 2012
Occludin is a direct target of thyroid transcription factor-1 (TTF-1/NKX2-1)E Aaron Runkle, Shawn J Rice, Ji Qi, et al.
The Journal of Biological Chemistry|April 30, 2013
MicroRNA-33a mediates the regulation of high mobility group AT-hook 2 gene (HMGA2) by thyroid transcription factor 1 (TTF-1/NKX2-1)Shawn J Rice, Shao-Chiang Lai, Lauren W Wood, et al.
The American Journal of Pathology|July 18, 2016
Occludin S490 Phosphorylation Regulates Vascular Endothelial Growth Factor-Induced Retinal NeovascularizationXuwen Liu, Alyssa Dreffs, Monica Díaz-Coránguez, et al.
Cell Reports|September 15, 2015
Disabling of the erbB Pathway Followed by IFN-γ Modifies Phenotype and Enhances Genotoxic Eradication of Breast TumorsYasuhiro Nagai, Hiromichi Tsuchiya, E Aaron Runkle, et al.
Experimental and Molecular Pathology|October 2, 2012
Reversion of the ErbB malignant phenotype and the DNA damage responseE Aaron Runkle, Hongtao Zhang, Zheng Cai, et al.
Pageof 1